(15 Mar 2010)
Argutus Medical have been shortlisted for the 'small business marketing award' at this years all Ireland Marketing Awards
(01 Feb 2010)
Argutus exhibited and presented at the 15th International conference on continuous renal replacement therapties in San Diego on February 24-27
(13 Nov 2009)
The Irish Medical Devices Association has declared Argutus Medical "emerging company of the year 2009".
(13 Oct 2009)
As we draw closer to FDA qualification here is a summary of the ILSI HESI Nephrotoxicity project to date.
(14 Sep 2009)
The Safer And Faster Evidence-based Translation consortium (SAFE-T) announces the start of work to qualify biomarkers for drug-induced kidney, liver and vascular injury in translational studies and seek for regulatory acceptance in translational and clinical contexts
(28 Jul 2009)
We have decided to make available some of our panel of amazing kidney specific antibodies (mostly human).
(21 Jul 2009)
Argutus Medical, Ireland has named CeeTox Inc., Kalamazoo, MI, a preferred reference laboratory for the novel acute kidney injury (AKI) biomarker panel "the AKI Test®". In addition, CeeTox will also run Argutus' assays for kidney toxicity of the proximal tubule, distal tubule collecting duct and loop of Henle.
(14 Jul 2009)
Argutus Medical will be attending AACC in Chicago July 19th - 23rd.
(11 Jun 2009)
Argutus Medical to chair meeting on the use of Biomarkers in Clinical Trials
(09 Jun 2009)
The first edition of the Argutus Medical eNewsletter is now available